CAMK2G expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 6.88527013181783E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.89730017755119E-10 |
Normal-vs-Stage2 |
1.61729996062121E-09 |
Normal-vs-Stage3 |
1.58850710363367E-12 |
Normal-vs-Stage4 |
6.93112234273485E-13 |
Stage1-vs-Stage2 |
1.382980E-01 |
Stage1-vs-Stage3 |
4.401600E-02 |
Stage1-vs-Stage4 |
1.912370E-02 |
Stage2-vs-Stage3 |
9.636400E-01 |
Stage2-vs-Stage4 |
6.865200E-01 |
Stage3-vs-Stage4 |
5.568000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.72482036933752E-12 |
Normal-vs-AfricanAmerican |
1.32020000043198E-07 |
Normal-vs-Asian |
4.920400E-01 |
Caucasian-vs-AfricanAmerican |
6.393800E-01 |
Caucasian-vs-Asian |
4.938100E-03 |
AfricanAmerican-vs-Asian |
4.370500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.30004904011594E-12 |
Normal-vs-Female |
1.04940001133258E-09 |
Male-vs-Female |
1.072470E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.66950999999083E-05 |
Normal-vs-Age(41-60Yrs) |
5.13820097580719E-11 |
Normal-vs-Age(61-80Yrs) |
5.93325388820176E-12 |
Normal-vs-Age(81-100Yrs) |
1.5450000000472E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.795800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.528000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.754400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.733400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.610800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.255800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.021200E-03 |
Normal-vs-Grade 2 |
1.78829950847614E-10 |
Normal-vs-Grade 3 |
2.92565971449221E-12 |
Normal-vs-Grade 4 |
4.80393502755305E-12 |
Grade 1-vs-Grade 2 |
1.204340E-03 |
Grade 1-vs-Grade 3 |
8.16680000000902E-05 |
Grade 1-vs-Grade 4 |
5.86379999999442E-05 |
Grade 2-vs-Grade 3 |
7.976200E-02 |
Grade 2-vs-Grade 4 |
9.131600E-02 |
Grade 3-vs-Grade 4 |
6.515400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.74060013466726E-10 |
Normal-vs-ccB subtype |
3.18478576843972E-12 |
ccA subtype-vs-ccB subtype |
2.561700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.17359455487076E-11 |
Normal-vs-N1 |
6.155300E-04 |
N0-vs-N1 |
8.702400E-01 |
|
|